Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vera Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +4 vs. Q3 2022
- Shares held
- 21.3M
- −207.2K (−1.0%) vs. Q3 2022
- Total value
- $412.8M
- −$46.3M (−10.1%) vs. Q3 2022
- New holders
- 10
- 23 more added
- Sold out
- 6
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,148,646 | $80.3M | 0.01% | +92,305+2.3% | Added |
| Sofinnova Investments, Inc. | 3,181,442 | $61.6M | 3.74% | 00.0% | Unchanged |
| Abingworth LLP | 2,960,231 | $57.3M | 18.87% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,991,473 | $38.5M | 0.04% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 1,409,098 | $27.3M | 4.18% | −127,083−8.3% | Reduced |
| Millennium Management LLC | 1,108,649 | $21.5M | 0.02% | +711,721+179.3% | Added |
| BlackRock Inc. | 875,884 | $16.9M | 0.00% | +85,089+10.8% | Added |
| Vanguard Group Inc | 767,533 | $14.9M | 0.00% | +8,701+1.1% | Added |
| Octagon Capital Advisors LP | 665,156 | $12.9M | 2.00% | +131,892+24.7% | Added |
| Polar Asset Management Partners Inc. | 414,000 | $8.01M | 0.11% | −109,400−20.9% | Reduced |
| Eversept Partners, LP | 411,308 | $7.96M | 0.76% | +255,179+163.4% | Added |
| Vivo Capital, LLC | 400,666 | $7.75M | 0.94% | −266,000−39.9% | Reduced |
| Baker Bros. Advisors LP | 333,333 | $6.45M | 0.04% | 00.0% | Unchanged |
| Alphabet Inc. | 301,580 | $5.84M | 0.34% | 00.0% | Unchanged |
| Logos Global Management LP | 285,000 | $5.51M | 0.65% | +285,000 | New |
| International Biotechnology Trust PLC | 281,257 | $5.43M | 1.68% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 257,066 | $4.97M | 0.00% | +17,266+7.2% | Added |
| State Street Corp | 256,696 | $4.97M | 0.00% | +6,913+2.8% | Added |
| Walleye Capital LLC | 229,204 | $4.44M | 0.10% | +229,204 | New |
| Woodline Partners LP | 149,553 | $2.89M | 0.04% | −19,724−11.7% | Reduced |
| Northern Trust Corp | 125,481 | $2.43M | 0.00% | +10,611+9.2% | Added |
| JPMorgan Chase & Co | 113,982 | $2.21M | 0.00% | +38,652+51.3% | Added |
| Nuveen Asset Management, LLC | 98,136 | $1.90M | 0.00% | +8,470+9.4% | Added |
| Bank of New York Mellon Corp | 71,770 | $1.39M | 0.00% | +2,272+3.3% | Added |
| Bank of America Corp | 51,676 | $999.9K | 0.00% | +17,279+50.2% | Added |
| Charles Schwab Investment Management Inc | 38,859 | $751.9K | 0.00% | +969+2.6% | Added |
| Swiss National Bank | 35,900 | $694.7K | 0.00% | +1,200+3.5% | Added |
| Pura Vida Investments, LLC | 35,372 | $684.4K | 0.11% | +35,372 | New |
| Moore Capital Management, LP | 25,000 | $483.8K | 0.01% | +25,000 | New |
| Renaissance Technologies LLC | 24,900 | $482.0K | 0.00% | +24,900 | New |
| Alps Advisors Inc | 18,749 | $362.8K | 0.00% | +4,005+27.2% | Added |
| California State Teachers Retirement System | 18,697 | $361.8K | 0.00% | +362+2.0% | Added |
| Rhumbline Advisers | 18,053 | $349.0K | 0.00% | +453+2.6% | Added |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $345.0K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 17,816 | $344.7K | 0.00% | −3,300−15.6% | Reduced |
| Jump Financial, LLC | 17,600 | $340.6K | 0.02% | +17,600 | New |
| Two Sigma Investments, LP | 17,017 | $329.3K | 0.00% | +17,017 | New |
| Carnegie Mellon University | 16,060 | $310.8K | 0.17% | 00.0% | Unchanged |
| Morgan Stanley | 15,553 | $301.0K | 0.00% | −7,407−32.3% | Reduced |
| State of Wisconsin Investment Board | 14,156 | $273.9K | 0.00% | −895−5.9% | Reduced |
| Barclays PLC | 13,279 | $256.9K | 0.00% | +3,254+32.5% | Added |
| Dimensional Fund Advisors LP | 11,498 | $223.0K | 0.00% | +11,498 | New |
| New York State Common Retirement Fund | 11,013 | $213.1K | 0.00% | −30.0% | Reduced |
| Walleye Trading LLC | 10,945 | $211.8K | 0.01% | +10,945 | New |
| Cambridge Trust Co | 9,887 | $191.0K | 0.01% | 00.0% | Unchanged |
| Credit Suisse AG | 9,558 | $184.9K | 0.00% | −109−1.1% | Reduced |
| Gyon Technologies Capital Management, LP | 9,413 | $182.1K | 0.07% | −11,018−53.9% | Reduced |
| MetLife Investment Management | 8,881 | $171.8K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 6,778 | $131.2K | 0.00% | +127+1.9% | Added |
| Deutsche Bank AG | 6,348 | $122.8K | 0.00% | +92+1.5% | Added |
| Legal & General Group Plc | 5,906 | $114.3K | 0.00% | +520+9.7% | Added |
| Royal Bank of Canada | 2,533 | $49.0K | 0.00% | +1,862+277.5% | Added |
| Amalgamated Bank | 2,203 | $43.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,041 | $20.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 897 | $17.4K | 0.00% | −4,401−83.1% | Reduced |
| Tower Research Capital LLC (TRC) | 531 | $10.0K | 0.00% | −1,004−65.4% | Reduced |
| Ameritas Investment Partners, Inc. | 1,061 | $9.69K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 467 | $9.04K | 0.00% | −783−62.6% | Reduced |
| Nisa Investment Advisors, LLC | 17 | $0 | 0.00% | +17 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,578,820−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −121,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5,183−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −231−100.0% | Sold out |